DnB Asset Management AS Has $10.07 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

DnB Asset Management AS lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 46.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 33,551 shares of the company’s stock after selling 29,000 shares during the quarter. DnB Asset Management AS’s holdings in HCA Healthcare were worth $10,070,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Whipplewood Advisors LLC bought a new stake in HCA Healthcare in the fourth quarter worth $31,000. Tidemark LLC acquired a new position in shares of HCA Healthcare during the 4th quarter valued at about $36,000. Legacy Investment Solutions LLC bought a new stake in HCA Healthcare during the third quarter worth approximately $39,000. Activest Wealth Management raised its position in shares of HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. boosted its holdings in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Down 0.0 %

HCA opened at $342.25 on Friday. The firm has a market cap of $84.26 billion, a price-to-earnings ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm’s 50-day simple moving average is $324.53 and its 200-day simple moving average is $341.25.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the company posted $5.90 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.84%. HCA Healthcare’s payout ratio is currently 13.11%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent analyst reports. Royal Bank of Canada lowered their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research report on Monday, January 27th. Barclays dropped their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Morgan Stanley decreased their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Finally, Bank of America decreased their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.